Drug profile · INN
medroxyprogesterone
RALOVERA
medroxyprogesterone (RALOVERA) is a progesterone receptor agonist. Associated with Pfizer Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — medroxyprogesterone
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.81
Quick answer
medroxyprogesterone (RALOVERA) is a progesterone receptor agonist. Associated with Pfizer Australia Pty Ltd.
Key facts
INN medroxyprogesterone
Brand RALOVERA
Mechanism Progesterone receptor agonist
Target Progesterone receptor
Originator Pfizer Australia Pty Ltd
Mechanism of action
Progesterone receptor agonist
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is medroxyprogesterone?
medroxyprogesterone (RALOVERA) is a progesterone receptor agonist. Associated with Pfizer Australia Pty Ltd.
What is the brand name for medroxyprogesterone?
RALOVERA is a marketed brand name for medroxyprogesterone. Check FDA Drugs@FDA for the current US label holder and prescribing information.